<DOC>
	<DOC>NCT01159483</DOC>
	<brief_summary>PF-04958242 in single doses will be safe and well tolerated by healthy volunteers.</brief_summary>
	<brief_title>First-In-Human Study Of PF-04958242 In Healthy Volunteers</brief_title>
	<detailed_description>To test the safety, tolerability and pharmacokinetics of PF-04958242 in healthy volunteers.</detailed_description>
	<criteria>healthy volunteers, male and female, ages 2155 No women of childbearing potential, no risk factors for seizures, no risk factors for QTc prolongation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>